Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-28 @ 7:27 PM
Study NCT ID:
NCT04526132
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2020-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
Sponsor:
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-21
First Submit QC Date:
None
Study First Post Date:
2020-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-18
Last Update Post Date:
2023-05-22
Last Update Post Date Type:
ACTUAL